TrialInternational journal of molecular sciences2021

Percutaneous Coronary Intervention (PCI) Reprograms Circulating Extracellular Vesicles from ACS Patients Impairing Their Cardio-Protective Properties.

Saveria Femminò et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.